263 related articles for article (PubMed ID: 15132984)
1. Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles.
Nemes Z; Devreese B; Steinert PM; Van Beeumen J; Fésüs L
FASEB J; 2004 Jul; 18(10):1135-7. PubMed ID: 15132984
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA
Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469
[TBL] [Abstract][Full Text] [Related]
3. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
[TBL] [Abstract][Full Text] [Related]
4. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains.
Doss-Pepe EW; Chen L; Madura K
J Biol Chem; 2005 Apr; 280(17):16619-24. PubMed ID: 15718234
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.
Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y
Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies.
Nemes Z; Petrovski G; Aerts M; Sergeant K; Devreese B; Fésüs L
J Biol Chem; 2009 Oct; 284(40):27252-64. PubMed ID: 19651786
[TBL] [Abstract][Full Text] [Related]
8. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.
Björkdahl C; Sjögren MJ; Zhou X; Concha H; Avila J; Winblad B; Pei JJ
J Neurosci Res; 2008 May; 86(6):1343-52. PubMed ID: 18061943
[TBL] [Abstract][Full Text] [Related]
9. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease.
Norlund MA; Lee JM; Zainelli GM; Muma NA
Brain Res; 1999 Dec; 851(1-2):154-63. PubMed ID: 10642839
[TBL] [Abstract][Full Text] [Related]
10. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
[TBL] [Abstract][Full Text] [Related]
11. Stress proteins in Alzheimer's disease.
Smith RC; Rosen KM; Pola R; Magrané J
Int J Hyperthermia; 2005 Aug; 21(5):421-31. PubMed ID: 16048839
[TBL] [Abstract][Full Text] [Related]
12. [Recent neuropathology of parkinsonian syndromes].
Duyckaerts C; Verny M; Hauw JJ
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S11-8. PubMed ID: 12773883
[TBL] [Abstract][Full Text] [Related]
13. The prion protein in human neurodegenerative disorders.
Kovacs GG; Zerbi P; Voigtländer T; Strohschneider M; Trabattoni G; Hainfellner JA; Budka H
Neurosci Lett; 2002 Sep; 329(3):269-72. PubMed ID: 12183028
[TBL] [Abstract][Full Text] [Related]
14. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
15. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
Iwai A
Biochim Biophys Acta; 2000 Jul; 1502(1):95-109. PubMed ID: 10899435
[TBL] [Abstract][Full Text] [Related]
16. Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease.
Terni B; Rey MJ; Boluda S; Torrejón-Escribano B; Sabate MP; Calopa M; van Leeuwen FW; Ferrer I
Acta Neuropathol; 2007 Apr; 113(4):403-16. PubMed ID: 17237936
[TBL] [Abstract][Full Text] [Related]
17. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam.
Yamazaki M; Arai Y; Baba M; Iwatsubo T; Mori O; Katayama Y; Oyanagi K
J Neuropathol Exp Neurol; 2000 Jul; 59(7):585-91. PubMed ID: 10901229
[TBL] [Abstract][Full Text] [Related]
19. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
Lee VM; Giasson BI; Trojanowski JQ
Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
[TBL] [Abstract][Full Text] [Related]
20. Derlin-1-immunopositive inclusions in patients with Alzheimer's disease.
Honjo Y; Ito H; Horibe T; Shimada H; Nakanishi A; Mori H; Takahashi R; Kawakami K
Neuroreport; 2012 Jul; 23(10):611-5. PubMed ID: 22627700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
